Aug 13, 2019
Soligenix Announces Recent Accomplishments And Second Quarter 2019 Financial Results
Jul 31, 2019
Soligenix Announces Conference Presentations Demonstrating Formulations of Single and Multivalent Ebola Subunit Vaccines
Jul 29, 2019
Soligenix Receives European Patents for Oral BDP in the Treatment of Acute Radiation Injury of the Gastrointestinal Tract
Jul 08, 2019
Soligenix Announces Appointment of Diane L. Parks to its Board of Directors
Jun 13, 2019
Soligenix to Present RiVax® Program at the 13 Annual CounterACT Network Research Symposium
May 28, 2019
Soligenix Announces $600,000 Subaward Supporting Evaluation of Innate Defense Regulator Platform Technology as a Medical Countermeasure for Bacterial Threat Agents
May 14, 2019
Soligenix Announces Recent Accomplishments And First Quarter 2019 Financial Results
Apr 23, 2019
Soligenix -- Advancing to Important Inflection Points With Two Pivotal Phase 3 Clinical Trials
Apr 18, 2019
Soligenix Achieves Significant Enrollment Milestone for its Pivotal Phase 3 Clinical Trial of SGX942 in the Treatment of Oral Mucositis in Head and Neck Cancer
Apr 09, 2019
Soligenix and the European Medicines Agency Pediatric Committee Reach Agreement on the Pediatric Investigation Plan for SGX942
Apr 04, 2019
Soligenix Receives US Patent for Dusquetide Related Analogs
Mar 26, 2019
Soligenix Announces Recent Accomplishments and Year-End 2018 Financial Results
Mar 18, 2019
Soligenix to Present at National Institutes of Health - Commercialization Accelerator Program "FeedForward Session" in Washington, DC
Mar 11, 2019
Soligenix to Present at the Boston Oncology Investor Conference 2019
Feb 11, 2019
Soligenix Receives US Patent Expanding Protection for its Ricin Toxin Vaccine, RiVax®
Feb 07, 2019
Soligenix Announces Publication Demonstrating Thermostabilization of an Ebola Subunit Vaccine Candidate
Jan 23, 2019
Soligenix Receives European Patent for Dusquetide and Related Innate Defense Regulator Analogs
Dec 11, 2018
Soligenix to Receive $611,000 in Non-Dilutive Funding Through New Jersey Technology Business Tax Certificate Transfer Program
Dec 05, 2018
Soligenix Announces Publication of Scientific Review Discussing Clinical Applications of Innate Defense Regulator Technology
Nov 12, 2018
Soligenix Selected to Present RiVax® Data at the Fourth International Conference on Vaccines Research & Development in Baltimore, Maryland